Miniature models of human organs may provide a more accurate predictor of drug efficacy than animal testing.

Solute carrier kidney transporter (SLC) models are essential for determining the renal clearance of drugs, environmental compounds, and endogenous molecules. Three different hTERT-immortalized ...

A groundbreaking 3D, three-layer nanomatrix vascular sheet that possesses multiple features of atherosclerosis has been applied for developing a high-throughput functional assay of drug candidates ...

The new Malaria-on-a-Chip model offers a promising approach to drug discovery using human-based models and paves the way for new drug development in collaboration with MMV.

CAMBRIDGE, Mass.-- (BUSINESS WIRE)-- Parallel Bio, a biotech company pioneering human-first drug discovery, today announced it has raised $21 million Series A funding, led by AIX Ventures. The ...

With support from EDB and A*Star, Japanese biopharma leader Chugai is using its research base in Singapore to create new therapies for global markets Read more at straitstimes.com. Read more at ...

Media contact: Jeff Hansen Ho-Wook Jun, Ph.D., Photography: Steve Wood A groundbreaking 3D, three-layer nanomatrix vascular sheet that possesses multiple features of atherosclerosis has been applied ...

Liver toxicity is a big problem in the drug, food, and consumer products industries, especially because results in animal models fail to predict how chemicals will affect humans. A new Liver-Chip ...

Once thought improbable, in vitro human models are demonstrating technological prowess in a growing range of applications.

Recent breakthroughs in making stem-cell based human embryo models are raising urgent questions about to what extent they should be treated like natural embryos and whether they are open to misuse.